Arundhati Parmar
Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts. Previously, she was Senior Editor at UBM's Medical Device + Diagnostic Industry. Arundhati has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again. Contact her at aparmar@medcitynews.com.
LinkedIn: https://www.linkedin.com/in/arundhati-parmar/
Twitter: @aparmarbb
-
From JPM Week: Trends That Life Science Experts Are Watching in 2023
Boston Consulting Group hosted a panel during the annual J.P. Morgan Healthcare Conference in which Merck’c chief strategy officer, a healthcare leader from Goldman Sachs, an investment executive and a senior medical devices executive from Medtronic weighed in on trends the life sciences industry can expect to see in 2023.
-
A VC’s take on the $1.3 billion acquisition of CinCor Pharma by AstraZeneca
Maina Bhaman, a board member of CinCor Pharma reflects on the news from Monday that AstraZeneca is acquiring the Massachusetts startup to bring another option for patients with resistant hypertension.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
CommonSpirit Health CEO at JPM: Some providers will be commodities
In an interview with MedCity News after his presentation at the J.P. Morgan Healthcare Conference, Wright Lassiter III said while some providers will be considered commodities, his vision for CommonSpirit Health is not to be “at the bottom of the totem pole.”
-
MedCity Pivot Podcast: What does the CEO of Zocdoc believe the future of telehealth to be?
Kharraz made a bold declaration about telehealth back in December 2020. In the final episode of 2022, we ask him about that and more.
-
Is Legislation to Safeguard Americans Against Superbugs a Boondoggle or Breakthrough?
The PASTEUR Act, as amended, would provide $6 billion in federal funding over several years to give drugmakers incentive to develop and manufacture lifesaving medications for the small but growing number of infections highly resistant to antibiotics.
-
Medcity Pivot Podcast: A Conversation With COTA CEO Miruna Sasu About RWE
Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However, will such efforts continue amidst the ongoing belt-tightening in a tough economy?
-
Are We in a Recession? Executives at HLTH Weigh In
MedCity News interviewed CEOs of public companies, entrepreneurs, VCs and payers at the HLTH conference that concluded last week. They had a range of answers to the question. But one common theme emerged: Currently, everyone has a vise-like grip on expenditure.
-
MedCity Pivot podcast: A chat with executive search firm CEO Sonia Millsom
In this episode, we are conversing with Sonia Millsom, CEO of executive search firm Oxeon, to discuss trends shaping the marketplace following the Great Resignation as well as how Oxeon is spurring innovation through its venture studio.
-
What is CMS’ position on telehealth reimbursement when the public health emergency ends?
In a conference session on Friday in Chicago, CMS Administrator Chiquita Brooks-LaSure said that Congress has authorized the agency to reimburse telehealth through Medicare permanently – in other words, even beyond the pandemic.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
How Emblem Health’s CFO is looking at reforming prior authorization
Emblem Health’ s chief financial officer knows that prior authorization — where patients have to […]
-
Should the same entity be allowed to own a retail pharmacy, a PBM and an insurance company?
The question elicited predictable and unexpected responses from panelists that included a senior executive from CVS Caremark and executives from startup companies working to change the pharmacy benefits landscape.
-
A preview of INVEST 2023: Themes and networking opportunities revealed
Save the date for INVEST 2023, which will take place on May 22-24 at the Ritz Carlton hotel in Chicago. The conference unites novel startups with active investors, highlights payer and provider perspectives, identifies challenges and opportunities in the life sciences, and describes healthcare’s overall transformation.
-
Consumer / Employer, Health Tech
Pivot Podcast: Hinge Health CEO Dan Perez exhorts all healthtech firms to validate, publish results
Digital health technologies have received plenty of attention, cash and sky-high valuations but do they deserve it? In the latest episode of MedCity’s Pivot podcast, CEO of Hinge Health says companies need to validate their results in order to move the industry forward.
-
Glen Tullman on launching Transcarent Pharmacy Care: Unlike others, we are a one-stop-shop
Transcarent is the latest to join a long list of companies hoping to transform the world of pharmacy benefits and prescription drugs. But its CEO declares Transcarent is marrying healthcare delivery with easy, affordable access to pharmaceuticals and creating a more unified experience for employees.
-
Impending hospital closure rattles Atlanta’s Healthcare landscape
Despite banners proclaiming Atlanta Medical Center’s commitment to the area — “120 Years Caring For Atlanta,” one reads — its nonprofit owner, Wellstar Health System, recently announced plans to close the hospital’s doors on Nov. 1.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
